Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Urinary Markers/Cytology. What and When Should a Urologist Use
Jeffrey M. Tomasini
,
Badrinath R. Konety
Urology
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Urinary Markers/Cytology. What and When Should a Urologist Use'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bladder Cancer
100%
Bladder Cancer Diagnosis
50%
Common Cancers
100%
Initial Diagnosis
50%
Non-invasive Method
50%
Non-muscle Invasive
50%
Non-muscle Invasive Bladder Cancer (NMIBC)
50%
Recurrent Disease
50%
Urinary Biomarkers
50%
Urinary Markers
100%
Urinary Tumor Marker
50%
Urologists
100%
Medicine and Dentistry
Biological Marker
33%
Bladder Cancer
66%
Bladder Cancer Diagnosis
33%
Cytotechnology
100%
Malignant Neoplasm
66%
Non Invasive Procedure
33%
Non Muscle Invasive Bladder Cancer
33%
Recurrent Disease
33%
Tumor Marker
33%
Urinary System
100%
Urologist
100%